Dog Relaxants Market By Product Type (Prescription Relaxants {Benzodiazepines, Tricyclic Antidepressants, Selective Serotonin Reuptake Inhibitors, Others}, Over-the-Counter (OTC) Relaxants {Herbal Remedies, Nutritional Supplements, Others}), By Application (Behavioral Anxiety {Separation Anxiety, Noise Phobias, Travel Anxiety, Generalized Anxiety Disorder}, Medical Conditions {Pre- and Post-Surgery Relaxation, Pain Management, Epilepsy and Seizures, Others}), By Formulation (Tablets and Capsules, Liquid Drops, Powders, Transdermal Patches, Injectable Solutions), By Distribution Channel (Online, Offline {Hospitals, Veterinary Clinics, Pet Specialty Stores, Others}), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Published Date: Jan 2025 | Report ID: MI1714 | 210 Pages

Industry Outlook

The Dog Relaxants market accounted for USD 186.2 Million in 2024 and is expected to reach USD 505.3 Million by 2035, growing at a CAGR of around 9.5% between 2025 and 2035. The dog relaxants market aims to produce medications that reduce anxiety and tension in dogs while also avoiding excessive activity. Some of them include natural non-prescription foods and supplements, as well as prescribed and over-the-counter drugs designed to treat disorders such as separation anxiety, noise phobia, and travel-related stress.

The market is expanding as more people own pets and become aware of their psychological status. Organic and homeopathic medicines are primary priorities, and goods may include chamomile, valerian root, or CBD. Medication for extreme anxiety is only prescribed by a veterinarian. It also capitalizes on pet humanization trends and an increasing demand for premium pet care goods.

Report Scope:

ParameterDetails
Largest MarketNorth America
Fastest Growing MarketEurope
Base Year2024
Market Size in 2024USD 186.2 Million
CAGR (2025-2035)9.5%
Forecast Years2025-2035
Historical Data2018-2024
Market Size in 2035USD 505.3 Million
Countries CoveredU.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, Switzerland, Sweden, Finland, Netherlands, Poland, Russia, China, India, Australia, Japan, South Korea, Singapore, Indonesia, Malaysia, Philippines, Brazil, Argentina, GCC Countries, and South Africa
What We CoverMarket growth drivers, restraints, opportunities, Porter’s five forces analysis, PESTLE analysis, value chain analysis, regulatory landscape, pricing analysis by segments and region, company market share analysis, and 10 companies
Segments CoveredProduct Type, Application, Formulation, Distribution Channel, and Region

To explore in-depth analysis in this report - Request Free Sample Report

Market Dynamics

A growing number of households globally are adopting dogs, boosting demand for pet care products, including relaxants

The global dog relaxants market is driven by the increasing demand for dogs as pets. This has raised the pace at which pet owners seek items to alleviate their pet's tension, resulting in increased demand for relaxants. Growing concern and awareness about dogs' mental well-being have led to a growth in demand for these items, as dog owners recognize the need to assist their dogs in overcoming anxiety, stress while alone, and other behavioral issues. Furthermore, demographic trends and the resulting increased encroachment of the urban environment on dogs' living conditions, including noise and crowding, have increased the demand for effective animal soothing measures.

Veterinary advancements and enhancements to natural, herbal, and CBD products, including relaxants, have also aided in wider development. Consumer trust in these relaxants has also been strengthened by veterinarian recommendations for these medications to improve overall behavior change. Furthermore, technological advancements have made it possible for many e-commerce platforms to make various formulations of dog relaxants freely accessible and purchasable. This has, in some ways, increased demand for dog relaxants, owing to the increased focus on pet care in modern culture.

Owners are more conscious of conditions like anxiety, stress, and separation anxiety in dogs, leading to increased use of calming products

The dog relaxant market is spurred by pet owners' growing concern for their canines' psychological well-being. Other problems, such as anxiety, stress, or separation anxiety, have become more widespread, particularly in homes with pets stuck in noisy and high-stress environments, such as cities. Veterinarians encourage this understanding by promoting safe and effective methods for managing such behaviors. Residents in the United States are trending toward "pet humanization," in which pets become part of the home, contributing to the dogs' comfort and mental health, and therefore increasing the popularity of natural and creative treats, such as CBD- and herbal sedatives.

E-commerce sector growth refers to the ease of access to a diverse selection of relaxing items as more businesses make and offer them. The snacks, sprays, and diffusers produced to address the many options contribute to market acceptability. Approval of certain substances has also given these goods a lot of respect, and the growing global pet population has bolstered demand.

The pricing of organic and specialized relaxants can be a barrier for budget-conscious pet owners.

The dog relaxant market confronts numerous challenges that hinder its growth and acceptance. There is significant concern that many organic and specialty calming products are unreasonably expensive for owners of low-income and niche markets. Lack of understanding of pet health in developing countries is a similar factor, as most pet owners are ignorant of conditions such as anxiety or treatment options. These jurisdictions also evaluate the potential negative consequences of the drugs to be supplied, such as relaxants, which can create lethargy and dependency, leading clients to be cautious.

Product differentiation is visible in the market due to fragmented quality issues, disparities in product efficacy and safety, and the presence of various small-scale competitors. Legal restrictions, such as those on some features of CBD or other natural substances, make it difficult for these products to become available and hence spread to other regions of the world. The lack of veterinarian consultation for pet owners in rural and other underdeveloped areas significantly reduces the use of these products, as most owners rely on the doctor's recommendation when petitioning for a certain pet product.

Increasing pet adoption in India, China, and Brazil presents untapped market potential.

The dog relaxants market has enormous growth potential, particularly in countries where pet adoption has yet to occur, such as India, China, and Brazil. With rising populations in these areas due to urbanization, changes in per capita income and lifestyle patterns. Pet ownership operations have risen, with a greater emphasis on pet health and the need for drugs to help dogs cope with anxiety and stress. The ongoing rise of the middle class in these nations, with the growing trend of consumer migration to premium pet care, indicated the viability of dog relaxants.

The growth of the internet and online markets allows for market penetration in remote areas of the market. Another area of potential growth is the increased desire among pet owners for pure and organic products, which could lead to the development of new products like herbal or CBD pet relaxants. Collaborations with veterinarians and pet stores can help raise product awareness and market potential. Raising knowledge among the general public about the benefits of utilizing this non-lethal approach to address specific habits in dogs generates demand in segments where such information is lacking.

Rising preference for chemical-free options provides opportunities for companies offering herbal and CBD-based relaxants

The dog relaxants market presents enormous prospects because customers choose natural, chemical-free products. With a growing desire among pet owners for natural and healthy therapies for their pets, there is a significant likelihood of the emergence of companies that make herbal and CBD products, including relaxants. These natural products satisfy the needs of informed consumers who choose natural products because synthetic chemicals have a variety of unwanted effects. This could be a fantastic chance for manufacturers who are ready to introduce new products that give individuals relaxing benefits, such as chamomile, valerian, or hemp-based CBD.

The emphasis has turned towards personalizing the pet care solutions that will be supplied to owners. This opens up the possibility of developing particular formulations to address distinct types of anxiety, such as separation anxiety or noise phobia. Increasing regulation of CBD and herbal ingredients with constant changes in the legal requirements will encourage acceptance and market expansion. Future partnerships with veterinarians, pet stores, and online selling platforms will help go even further in popularizing and increasing the credibility of new natural dog relaxants quicker and smoother in the market.

Industry Experts Opinion

 "The dog relaxants market has seen impressive growth in recent years. More pet owners are becoming aware of the importance of mental health for their dogs, especially as they experience anxiety and stress in their daily lives. Products like calming treats, pheromone-based sprays, and anxiety wraps have proven to be effective in providing relief, and this has increased demand across the globe. We are seeing pet parents who are more proactive about their dog's wellness, making this market essential for promoting a healthy pet lifestyle."

  • Dr. Emily Richards, DVM, CEO of PetCalm Solutions

"At Zesty Paws, we take great pride in offering products that support both physical and emotional well-being for dogs. Our calming supplements are a part of this broader wellness approach. Dogs, like humans, need solutions for stress and anxiety. Our research-backed products have consistently helped pet owners provide comfort to their dogs, especially in stressful situations like travel or during thunderstorms. We're excited to be part of an industry that's helping improve pets' lives."

  • Mark Thompson, CEO of Zesty Paws

Segment Analysis

Based on the product type, the global Dog Relaxants Market is segmented into Prescription Relaxants and Over Counter (OTC) Relaxants. Prescription relaxants are the dog relaxants market leader because veterinarians frequently prescribe animal medicine to dogs for anxiety, behavioral issues, and other ailments, such as seizures or post-operative recovery. For anxiety and stress-related diseases in animals, benzodiazepines and SSRIs are more commonly used since they are more specific and pose fewer risks. Recognizing the significance of a pet's mental health, prescription medications such as relaxants will be expanded because they are more beneficial from a veterinarian's perspective.

 

Based on application, the Dog Relaxants Market is classified into Behavioral Anxiety, Medical Conditions. The largest category in the dog relaxants market is behavioral anxiety treatment, which has become a prevalent problem among pets as a result of environmental factors, loud noises, and isolation from their owners. The trend of treating pets as part of the family has resulted in a significant demand for items that alleviate anxiety-related behaviors. As consumers seek appropriate solutions to ensure their pet's comfort, the behavioral anxiety category is likely to keep a large market share.

Regional Analysis

The North American dog relaxant market is leading because of the region's high pet density, and an increasing number of pet owners are concerned about their pets' health and anxiety. In North America, there is widespread concern for the psychological and medical needs of pets, which has led to an increase in sales of both legally prescribed and over-the-counter animal relaxants. Local vets now provide desensitization techniques for behavioral anxiety, analgesics for pain, and antioxidants and nutrients for post-surgical pets. The pet care market is well developed, with strong distribution channels, which aids in the growth of the dog relaxants market in this region, as more and more owners seek to provide their pets with good health and effective therapies.

The European dog relaxant market is booming as people become more concerned about their pets' health. This demonstrates that pet owners in European countries respect their pets' mental and emotional well-being, and they are turning to relaxants to manage anxiety and behavioral issues. However, European customers' preference for natural, non-synthetic items has an impact on pet products in particular. The European veterinary industry is intimately involved in prescribing and administering dog relaxants, and pet owners prefer familiar healthcare goods. Furthermore, the norms and regulations governing pet medication are highly developed in European countries, so there is little risk of substandard items entering the market. This scenario contributes to consumer confidence and to the expansion of the market in that region.

Competitive Landscape

The dog relaxants market is persistent, with multiple suppliers offering a variety of options. Nestlé Purina Petcare, Virbac, and Zoetis Inc. are among the companies that currently sell both prescription and nonprescription products for viewing. NOW Foods and PetHonesty appear to do well with natural and holistic products to meet the demands of pet owners who shun drugs or chemicals. Zesty Paws has recently employed its soft chews to promote relaxation while also addressing other aspects of wellness. These firms are continually improving their products, with some focusing on stress reduction, anxiety for pets, and overall animal health and wellbeing, and marketing via e-commerce platforms.

Dog Relaxants Market, Company Shares Analysis, 2024

To explore in-depth analysis in this report - Request Free Sample Report

Recent Developments:

  • In November 2024, a leading company in pet care announced an expansion of its product line of calming products, with pheromone sprays and relaxation supplements. The products aim to reduce stress on dogs with seasonal changes and holidays. It was designed for fast action without sedation while effectively reducing anxiety. 
  • In October 2024, a prominent veterinary health brand unveiled an advanced model of its anxiety-reducing wrap that comes with adjustable, ergonomic designs for maximum comfort. This updated version can be ordered via veterinary clinics as well as through online portals for a wider pet owner population that is interested in non-invasive solutions.

Report Coverage:

By Product Type

  • Prescription Relaxants
    • Benzodiazepines
    • Tricyclic Antidepressants
    • Selective Serotonin Reuptake Inhibitors
    • Others
  • Over-the-Counter (OTC) Relaxants
    • Herbal Remedies
    • Nutritional Supplements
    • Others

By Application

  • Behavioral Anxiety
    • Separation Anxiety
    • Noise Phobias
    • Travel Anxiety
    • Generalized Anxiety Disorder
  • Medical Conditions
    • Pre- and Post-Surgery Relaxation
    • Pain Management
    • Epilepsy and Seizures
    • Others

By Formulation

  • Tablets and Capsules
  • Liquid Drops
  • Powders
  • Transdermal Patches
  • Injectable Solutions

By Distribution Channel

  • Online
  • Offline
    • Hospitals
    • Veterinary Clinics
    • Pet Specialty Stores
    • Others

By Region

North America

  • U.S.
  • Canada

Europe

  • U.K.
  • France
  • Germany
  • Italy
  • Spain
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Singapore
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America

Middle East & Africa

  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

List of Companies:

  • Nestlé Purina Petcare
  • Virbac
  • NOW Foods
  • Zoetis Inc.
  • PetHonesty
  • Zesty Paws
  • THUNDERWORKS
  • PetIQ, LLC
  • Ceva Animal Health
  • Garmon Corp.
  • Bach Rescue Remedy Pet
  • VetIQ
  • Vet’s Best
  • Calm Paws
  • Ark Naturals

Frequently Asked Questions (FAQs)

The Dog Relaxants market accounted for USD 186.2 Million in 2024 and is expected to reach USD 505.3 Million by 2035, growing at a CAGR of around 9.5% between 2025 and 2035.

Key growth opportunities in the Dog Relaxants Market include increasing pet adoption in India, China, and Brazil presents untapped market potential, rising preference for chemical-free options provides opportunities for companies offering herbal and CBD-based relaxants, and collaborations with veterinary clinics can enhance product credibility and sales.

Product type is dominating the Dog Relaxants Market by Prescription Relaxants. The current market for prescription-based relaxants including benzodiazepines and SSRIs is fueled by the high efficacy identified within these products, especially in treating anxiety and other behavioral disorders in dogs. It is common knowledge that these products are highly endorsed by veterinarians for serious conditions such as anxiety due to separation, noise, and travel.

North America leads the dog relaxants market due to a high pet ownership rate, with millions of households investing in pet health and wellness products. Increasing awareness of pet anxiety issues, coupled with a growing preference for natural and effective solutions, drives demand. Additionally, the presence of major pet care companies and advanced veterinary care options further supports market growth. E-commerce platforms also enhance accessibility, making these products readily available to a larger consumer base.

Key operating players in the Dog Relaxants Market are Zoetis, Merck & Co., Elanco Animal Health, Pet Naturals of Vermont, and ThunderShirt. These companies are market pioneers with a variety of prescription-based relaxants as well as other counter-anxiety agents available as remedies for anxiety and stress in dogs. These are factors such as market domination, sustaining product development, and a focus on partnerships with veterinarians. These firms are also using features such as the enhancement of pharmaceutical and natural compounds to meet the increasing consumer need for healthy and safe pet care products.

Maximize your value and knowledge with our 5 Reports-in-1 Bundle - over 40% off!

Our analysts are ready to help you immediately.